Literature DB >> 22891283

Vesicles released by activated T cells induce both Fas-mediated RIP-dependent apoptotic and Fas-independent nonapoptotic cell deaths.

Gábor Koncz1, Anikó Hancz, Krittalak Chakrabandhu, Péter Gogolák, Krisztina Kerekes, Eva Rajnavölgyi, Anne-Odile Hueber.   

Abstract

Activated T cells secrete Fas ligand (FasL)-containing vesicles (secreted vesicles) that induce death of target cells. We provide evidence that secreted vesicles from culture supernatants (Csup) of various origins are able to generate both Fas-dependent apoptotic and Fas-independent, nonapoptotic cell death. In the absence of Fas, the nonapoptotic, Fas-independent pathway could still induce cell death. In contrast to RIP-independent classical Fas-induced cell death triggered by cross-linked or membrane-bound FasL, CSup-derived stimuli-induced apoptosis exhibited unique molecular and enzymatic characteristics. It could be partially inhibited by blocking cathepsin D enzyme activity and required the presence of RIP. Whereas stimulation with CSup, derived from both FasL-overexpressing Jurkat cells and PBMC, could induce cell death, the requirements for Fas-associated death domain protein and caspase-9 were different between the two systems. Our study highlights an important distinction between cell contact-mediated and secreted vesicle-generated activation-induced cell death and also demonstrates that the type of the secreted vesicles can also modify the cell death route. We propose that besides cell-to-cell interaction-mediated Fas triggering, stimuli induced by secreted vesicles can mediate important additional cell death signals regulating activation-induced cell death under physiological conditions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22891283     DOI: 10.4049/jimmunol.1102827

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance.

Authors:  Amy V Paschall; Dafeng Yang; Chunwan Lu; Jeong-Hyeon Choi; Xia Li; Feiyan Liu; Mario Figueroa; Nicholas H Oberlies; Cedric Pearce; Wendy B Bollag; Asha Nayak-Kapoor; Kebin Liu
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

2.  Proapoptotic CD95L levels in normal human serum and sera of breast cancer patients.

Authors:  Vicente Olimón-Andalón; Adriana Aguilar-Lemarroy; Sarah Ratkovich-González; Aida Uribe-López; Ignacio Mariscal-Ramírez; Raúl Delgadillo-Cristerna; Pablo Ortiz-Lazareno; Georgina Hernández-Flores; Ruth de Celis; Alejandro Bravo-Cuellar; Luis F Jave-Suárez
Journal:  Tumour Biol       Date:  2015-01-04

3.  Plasma extracellular vesicles bearing PD-L1, CD40, CD40L or TNF-RII are significantly reduced after treatment of AIDS-NHL.

Authors:  Laura E Martínez; Shelly Lensing; Di Chang; Larry I Magpantay; Ronald Mitsuyasu; Richard F Ambinder; Joseph A Sparano; Otoniel Martínez-Maza; Marta Epeldegui
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

4.  Differential Interaction of Platelet-Derived Extracellular Vesicles With Circulating Immune Cells: Roles of TAM Receptors, CD11b, and Phosphatidylserine.

Authors:  Birgit Fendl; Tanja Eichhorn; René Weiss; Carla Tripisciano; Andreas Spittler; Michael B Fischer; Viktoria Weber
Journal:  Front Immunol       Date:  2018-12-11       Impact factor: 7.561

5.  Media studies to enhance the production of verticillins facilitated by in situ chemical analysis.

Authors:  Chiraz Soumia M Amrine; Huzefa A Raja; Blaise A Darveaux; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Ind Microbiol Biotechnol       Date:  2018-09-27       Impact factor: 3.346

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.